BioFire Diagnostics LLC, a bioMérieux company, leads the molecular diagnostics industry with innovative syndromic infectious disease testing solutions for clinical laboratories worldwide.
Import Shipments
Distribution Centers
Annual Revenue
Founded
BioFire Diagnostics has recently focused on expanding its syndromic testing panels, enhancing automation, and supporting global public health responses to emerging infectious diseases.
Introduction of expanded respiratory and fever panels, including rapid COVID-19 and multi-pathogen detection.
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
BioFire Diagnostics LLC develops and manufactures advanced molecular diagnostic systems, most notably the BioFire System, which delivers fast and accurate syndromic testing for infectious diseases. Their technology allows for the identification of multiple pathogens from a single patient sample, streamlining diagnosis and improving patient outcomes. The company serves hospitals, clinical laboratories, and healthcare providers, offering FDA-cleared and CE IVD-marked assays for global markets. As a subsidiary of bioMérieux, BioFire continues to innovate in the field of in vitro diagnostics.
Salt Lake City, Utah, USA
1990
Private company
